Ring Therapeutics says it has demonstrated the ability to encapsidate nucleic acid payloads through in vitro assembly.

Innovative delivery techniques, including high-tech nanoparticles and electroporationdevices, may convey more gene therapies into the clinic.

The prospectus describes RBD4059, one of Ribo Life's core candidate products, as the world's first and most advanced siRNA ...

STONY BROOK, NY / ACCESS Newswire / May 14, 2025 /Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), ...

AnelloBricks is a promising in vitro approach to producing a new class of functional viral vectors, offering dramatic ...

Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform ...

In this interview, industry expert Dr. Lohit Khera discusses the evolving role of microRNA in research, diagnostics, and ...

Fusobacteria, which are part of the oral microbiome, are suspected of playing a role in cancer progression. Scientists at the Helmholtz Institute for RNA-based Infection Research (HIRI) are working on ...

More information: Nicholas Marzano et al, Single-molecule visualization of sequence-specific RNA binding by a designer PPR protein, Nucleic Acids Research (2024). DOI: 10.1093/nar/gkae984 Heidar J ...

Funding will enable company to expand research capacity and scale up unique genome editing technology designed to treat ...

The treatment, which aimed to block production of a mutant protein, reduced the frequency of infant’s seizures, but did not ...